Chronic oral exposure to low-concentration fumonisin B2 significantly exacerbates the inflammatory responses of allergies in mice via inhibition of IL-10 release by regulatory T cells in gut-associated lymphoid tissue.

MLA

Ando, Mana, et al. “Chronic Oral Exposure to Low-Concentration Fumonisin B2 Significantly Exacerbates the Inflammatory Responses of Allergies in Mice via Inhibition of IL-10 Release by Regulatory T Cells in Gut-Associated Lymphoid Tissue.” Archives of Toxicology, vol. 97, no. 10, Oct. 2023, pp. 2707–19. EBSCOhost, https://doi.org/10.1007/s00204-023-03579-0.

APA

Ando, M., Yamaguchi, H., Morimoto, A., Iwashita, N., Takagi, Y., Nagane, M., Yoshinari, T., & Fukuyama, T. (2023). Chronic oral exposure to low-concentration fumonisin B2 significantly exacerbates the inflammatory responses of allergies in mice via inhibition of IL-10 release by regulatory T cells in gut-associated lymphoid tissue. Archives of Toxicology, 97(10), 2707–2719. https://doi.org/10.1007/s00204-023-03579-0

Chicago

Ando, Mana, Hiroki Yamaguchi, Ai Morimoto, Naoki Iwashita, Yoshiichi Takagi, Masaki Nagane, Tomoya Yoshinari, and Tomoki Fukuyama. 2023. “Chronic Oral Exposure to Low-Concentration Fumonisin B2 Significantly Exacerbates the Inflammatory Responses of Allergies in Mice via Inhibition of IL-10 Release by Regulatory T Cells in Gut-Associated Lymphoid Tissue.” Archives of Toxicology 97 (10): 2707–19. doi:10.1007/s00204-023-03579-0.